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No single agent has been found which accounts for the hyperemia and in- 
creased  vascular  permeability  associated  with  many  common  reactions  to 
injury.  Histamine  appears  to  be  important  in  some  reactions,  but  there  is 
abundant evidence that it is not the sole active agent, and in many reactions 
may not be the major factor. The following experiments demonstrate that the 
edema produced in the rat by ovomucoid and three other agents which dam- 
age  mast  cells is mediated by the combination of 5-hydroxytryptamine and 
histamine, or closely related substances. 
In  previous studies  (1)  of  the  acute  vascular  reaction produced  by ovo- 
mucoid  in  rats  it  was  shown  that  the  edematous  reaction in  the  skin  was 
related to the distribution and concentration of mast cells in this tissue. Hist- 
amine was found to be associated with  the mast  cells and was  shown to be 
released  from  tissues  by  ovomucoid.  These  parallelisms  suggested  that  the 
histamine  released might be a  major factor in  the production of hyperemia 
and edema in the rat. However, a direct correlation was not observed between 
the quantity of histamine released and the amount of edema produced. This 
finding  suggested that  another agent or agents present in  skin might be in- 
volved in the production of edema. 
The occurrence of material with the biological and chemical characteristics 
of  5-hydroxytryptamine in  rat  skin  and  its  association  with  mast  cells  (2) 
induced us to test synthetic 5-hydroxytryptamine for its capacity to produce 
increased  vascular  permeability and  edema.  When  injected  subcutaneously, 
5-hydroxytryptamine was  found  to  be  an  exceedingly potent  agent  in  this 
respect. This raised the question of whether 5-hydroxytryptamine, operating 
alone or in  combination with histamine,  might not mediate  the edema pro- 
* Aided in part by grants from the United States Public Health Service  (Grant No. H-1073), 
The Chicago Heart ASsociation,  The American Heart Association, and The Variety Club of 
Illinois. 
399 400  ~-B-YDROXYTRYPTAMIN'E  AND HISTAMINE  AND VASCULAR INJURY 
duced  by  ovomucoid  and  other  agents  which  damage  mast  cells.  The  work 
which  follows  provides  evidence  that  the  two  substances,  acting  together, 
do  in fact produce  the vascular  response  and  that  5-hydroxytryptamine,  or a 
closely related  substance,  is  the  major  active component. 
Material And Methods 
The substances injected to produce edema were: ovomucoid, dextran, 48/80, testis extract, 
5-hydroxytryptamine, and histamine.  ~ The concentrations of histamine and  5-hydroxytrypt- 
amine  are  recorded  as  micrograms of  free base  per milliliter while the  concentrations  of 
the other agents producing edema are recorded as micrograms of dry material per milliliter. 
These agents were diluted in fresh 0.86 per cent NaC1 and this diluent was used for  control 
injections. 
The edema-producing substances  were injected into the paws of rats.  Each paw was in- 
jected subcutaneously, using a tuberculin syringe and a 27 gauge long-bevel  needle. The needle 
was inserted between the 3rd and 4th digits to approximately the midpoint of the dorsum; 
0.05 ml. was injected into the forepaw and 0.10 ml. into the hind paw. The fore and hind paws 
on one side of the rat were used to measure the edema produced by a test agent; thus each 
rat was used to measure the edema produced by two agents or one agent and a saline control. 
Injections were rotated so that equal numbers  of determinations for each agent were made 
on the right and left sides of rats. 
Each rat was injected intravenously with 2 rag. of Evans blue in 0.5 ml. of saline imme- 
diately prior to subcutaneous  injections. Since Evans blue is adsorbed  to plasma proteins, 
the blue staining of edematous tissues indicated increased vascular permeability to plasma 
proteins as well as to water (3). 3 to 5 minutes after injection of appropriate concentrations 
of the edema-producing agents, bluing of the wheal occurred. By 30 minutes there was maxi- 
mum swelling and deep bluing of the entire dorsum of the foot that persisted for 4 or more 
hours. Injection of saline produced little or no bluing. The gross swelling from injection of sa- 
line subsided in about 2 hours; the edema was measured at this interval after challenge. 
To measure the edema produced by subcutaneous injections, the tissue water in paw skins 
was determined. The full thickness dorsal paw skins,  from the wrist and ankle to the inter- 
digital spaces, were carefully removed from anesthetized and  exsanguinated  rats.  The fore 
and hind paw skins from one side were combined for each determination. Each sample, fore 
and hind paw skin, was weighed and dried to constant weight at 100°C. for 5 days. Paw skin 
2 hours after saline injection contained about  75 per cent water; paw skin with maximum 
edema contained about 85 per cent water. In Text-figs. 1 and 2 the edema is recorded as the 
percentage change  in  tissue water between paw  skins injected with saline  and  paw  skins 
injected with edema-producing agents. The changes in tissue water were computed from an 
average value for paws injected with saline and an average value for paws injected with an 
edema-producing agent. 
10vomucoid was prepared  as previously described  (1).  Dextran with a  mean molecular 
weight of 80,000, the type used as a "plasma expander," was kindly supplied by Commercial 
Solvents Corporation, Terre Haute, Indiana. 48/80, the formaldehyde polymer of pomethoxy- 
phenethylmethylamine,  was kindly  supplied  by  Burroughs-Wellcome Co., Tuckahoe,  New 
York. Testis extract was a preparation (8 HY 11) used in previous studies: Benditt et al. Proc. 
Soc. Exp. Biol. and Med., 1951, 77, 643.  Synthetic 5-hydroxytryptamine creatinine sulfate 
was  supplied  through  the  courtesy  of  Dr.  George  Berryman,  Abbott  Laboratories,  Inc., 
North  Chicago.  Histamine  dihydrochloride  was  purchased  from  Eastman  Kodak  Co., 
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In repeated experiments the gross response, bluing and edema, graded from 0 to 4+, cor 
related well with water determinations. Invariably a 2+ gross response equalled a 2 to 3 per 
cent increase in tissue water and a 4+ gross response equalled a 5 per cent or more increase 
in tissue water. Therefore in several experiments gross grading of the response was used to 
measure the reaction. 
Mast cells were examined in hlstologic sections of the injected paw skins. The tissues were 
fixed in ethanol (80 per cent) and neutral formaldehyde (4 per cent), imbedded in paraffan, 
and sectioned at 5 #. Toluldine blue, 0.1 per cent in 0.01 ~ acetic acid with 50 per cent ethanol 
V/V was used for staining mast cells. 
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Tv.xT-Fzo.  1. Comparison of the edema produced by ovomucoid 50 #g./ml., histamine 200 
#g./ml., and  S-hydroxytryptamine  1 #g./ml., and also the inhibition of edema produced by 
these agents with dibenamine 8 mg./kg, and/or pyrilamine 4 mg./kg. 
Drugs used to inhibit edema were injected intravenously. Pyrilamine maleate (pyrilamlne) 
was dissolved in saline; Dibenamine hydrochloride (dibenamine) was dissolved 100 rag. per 
ml. of diluting fluid; immediately before use the stock solution of dibenamine was diluted in 
saline to give the required eoncentration.~ Drug doses were computed as milligrams per kilo- 
gram Of body weight. Concentrations of dibenamine and pyrilamine were adjusted so that 
equal volumes were given for all drug doses.  Control rats received saline and/or diluting fluid 
Pyrflamine  maleate  (also  known as neoantergan)  was  kindly  supplied  by Merck  and 
Co., Rahway, New Jersey. Dibenamine hydrochioride was kindly supplied by Smith, Kline, 
and  French Laboratories,  Philadelphia,  the  stock-diluting fluid formula recommended  by 
them had the following composition: ethanol 48.5  ml., propylene glycol 48.4  ml., and  con- 
centmted HC1 0.2 ml. 402  5-HYDROXYTRYPTAMINE AND HISTAMINE AND VASCULAR INJURY 
diluted in saline. Dibenamine (or the control injection) was given 15 minutes, and pyrilamine 
(or the control injection) was given 10 minutes before local injections of the edema-producing 
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TExT-FIG.  2. Edema produced by 5-hydroxytryptamine and histamine alone and in com- 
bination compared with the edema produced by ovomucoid. Each point is the average of 4 
determinations. 
agents. These time intervals were selected after preliminary experiments demonstrated,  that 
pyrilamine inhibition of the edema produced by histamine subsided in about I hour, and that 
dibenamine inhibition of the edema produced by 5-hydroxytryptamine was maximum at 15 
minutes, though active for more than 4 but less than 24 hours after intravenous injection. 
Young adult,  female, Sprague-Dawley rats weighing 160 to 190 gm. and  maintained  on DONALD A. ROWLEY  AND EARL P. BENDITT  403 
Purina chow and water ad libiturn were used. Rats were anesthetized with ether for all injec- 
tions. 
EXPE~ ~t,F~'...NTA  L OBSERVATIONS 
Preliminary  Experiments.-- 
In a  series of pre|imin~ry  experiments,  concentrations  of each agent  were 
found which would produce edema of equal severity with about a S per cent 
increase in tissue water in the paw skins;  the concentrations were: ovomucoid 
S0 ~ag./ml., dextranS0/~g./ml., histamine 200 Izg./ml., andS-hydroxytryptamine 
1/~g./ml. Testis extract 1S0/~g./ml.  produced an equivalent increase in tissue 
water, but the edema was more diffuse, presumably owing to the presence  of 
hyaluronidase in the extract.  Each agent produced a  gelatinous edema simi- 
lar  to  that  found in rats  injected intravenously with ovomucoid (1). In Fig. 
1 the gross edemas produced by ovomucoid, histamine,  and  S-hydroxytrypt- 
amine are compared with the response produced by saline. 
It  was  found  that  dibenamine  S  mg./kg,  regularly  inhibited  the  edema 
produced  by  5-hydroxytryptamine  1  /Jg./mL,  and  pyrllamine  2.5  mg./kg. 
regularly inhibited the edema produced by histamine  200/Jg./ml.  In the fol- 
lowing experiments the doses of drugs were: dibenamine 8 mg./kg, and pyril- 
amine 4  mg./kg.  These doses were used to insure  adequate drug levels and 
were not  apparently  toxic.  Edema  produced  by histamine  and  edema  pro- 
duced by 5-hydroxytryptamine could be clearly differentiated by the use of 
these  antagonists:  Dibenamine  did  not  affect the  edema  produced by hist- 
amine and pyrilamine did not affect the edema produced by 5-hydroxytrypt- 
amine.  It was found that  dibenamine  partially  inhibited  but pyrilamine did 
not reduce the edema produced by ovomucoid. 
These results suggested that the edema produced by ovomucoid is mediated 
in  a  large  measure  by 5-hydroxytryptamine;  however,  the  results  did  not 
exclude histamine as a possibly active agent in the response.  In the following 
two  experiments  the  relative  participation  of  5-hydroxytryptamine  and 
histamine  in the edematous response to ovomucoid injection was examined. 
Inhibition  of  Ovomucoid-Produced Edema  by  Dibenaraine  and  Pyrilaraine.-- 
The  experiment was designed to test the effects of dibenamine  and  pyril- 
amine,  alone and in combination, on the edema produced by ovomucoid, by 
5-hydroxytryptamine,  and  by  histamine.  The  concentrations  of  the  three 
edema-producing  agents  were selected  to  produce an  equivalent  edematous 
response,  characterized  by approximately a  5 per cent increase  in paw skin 
water. 
Forty-eight rats were divided into four groups: One group of 12 control animals was  treated 
with saline and the dibenamine diluting fluid; the other groups of 12 animals each were treated 
with:  (a) dibenamine, (b) pyrilamine, and (c)  dibenamine and pyrilamine respectively. Each 404  ~-HYDROXYTRYPTAMINE  AND  HISTAR~INE AND  VASCULAR  INJURY 
rat was used to measure the response  produced by two agents (or one agent and saline); thus, 
the response to each  of the three edema-producing  agents and saline was measured six times 
in different rats in each group. 
The results, presented in  Text-fig. 1, show the changes in tissue water pro- 
duced by 5-hydroxytryptamine, histamine, and ovomucoid in the four groups of 
rats.  The changes in  tissue water were computed from an average base line 
value  derived  from  the  24  determinations  on  saline-injected  paws  in  the 
four groups.  There were no statistically significant differences in tissue water 
for saline-injected paws among the four treatment groups. The data clearly dem- 
onstrate  that  ovomucoid did not produce  edema  in  rats  treated  with  both 
drugs.  They also  show  that:  (a)  the  selected  doses  of  the  three  agents 
produced an  equivalent  edematous response  in  the control  animals,  (b)  di- 
benamine  inhibited  the  response  to 5-hydroxytryptamine without  affecting 
appreciably  the  edema  produced by histamine,  (c) pyrilamine inhibited  the 
edema produced by histamine  without  affecting  the  edema  produced  by 
5-hydroxytryptamine, (d)  dibenamine  alone  partially  inhibited  and  pyrila- 
mine alone did not affect edema produced  by ovomucoid, and  (e)  neither 5- 
hydroxytryptamine nor histamine  produced edema in rats  treated with  both 
drugs. 
These results  suggest  that  edema produced by ovomucoid is  mediated  in 
a  large part by 5-hydroxytryptamine and/or  related substances blocked by 
dibenamine.  However,  it  is  not  apparent  from  these  data  why  pyrilamine 
alone did not partially inhibit edema produced by ovomucoid. In the follow- 
ing experiment a  reasonable explanation for this finding is given. 
Edema  Produced  by  5-Flydroxytryptamine  and  H~stam~ne,  alone and  in 
Combination, Compared with the Edema Produced by Ovomucoid.-- 
The  possible  roles  of  5-hydroxytryptamine and  histamine  in  the  edema 
produced by  ovomucoid were  examined by  comparing  the  edema  produced 
by these two agents, alone and in combination, with the edema produced by 
ovomucoid. It was assumed that  the quantities of 5-hydroxytryptamine and 
histamine or related substances "released" by ovomucoid were directly related 
to  the  quantity  of  ovomucoid injected.  It  was  further  assumed  that  these 
agents were "released" in  approximately the ratio  they were present in  the 
subcutaneous  areolar  tissue  of  the  skin  of rat  feet. Assays  showed about  1 
part of 5-hydroxytryptamine to 16 to 26 parts of histamine in this tissue (2). 
Each of four serial twofold dilutions of (a)  5-hydroxytryptamine alone, (b)  histamine 
alone, (e) 5-hydroxytryptamine and histamine combined in the ratio of 1:24, and (d) ovo- 
mucoid was tested in four rats; saline  was tested in 16 rats. The ranges of concentrations  tested 
were selected to give from just measurable to near maximum edema. 
The results are plotted in Text-fig. 2. On the abscissa 1 ~g./ml. of 5-hydrox- 
ytryptamine  was  set  coincident  with  50  ug./ml,  of  ovomucoid  since  these DONALD  A. ROV~rLEY AND EARL P. BENDITT  405 
concentrations were  shown  previously to produce an  equivalent edematous 
response. The scale for histamine and the mixture of histamine and 5-hydroyx- 
tryptamine was then set by the ratio derived  from the assays. Each point is 
the average of four determinations. One curve is fitted to the points for hist- 
amine and the other to the points for ovomucoid. 
It is apparent that within the dose range selected:  (a)  there is increasing 
edema with increasing  concentrations  of the agents,  (b)  histamine is a much 
less potent edema-producing  agent than 5-hydroxytryptamiue, (c)  histamine 
added to 5-hydroxytryptamine increases only slightly the edema produced by 
5-hydroxytryptamine and, (d)  the form of the  dose response  curve  for  the 
edema  produced  by  ovomucoid  is  very  similar  to  that  produced  by 
5-hydroxytryptamine alone or  combined  with histamine. These findings are 
consistent with the suggestion that edema produced by ovomucoid is media- 
ted in  a  large  measure by the action of 5-hydroxytryptamine or  a  related 
substance.  Since histamine combined  with 5-hydroxytryptamine in  the ratio 
used produced only slightly greater edema  than 5-hydroxytryptamine alone, 
one  would  not  expect  an  appreciable  reduction in  edema by an antihista- 
minic drug. 
If the data are examined  in another way, it is apparent  that ovomucoid 
releases  histamine  as  weU  as  5-hydroxytryptamine (or  related  substances 
inhibited by pyrilamine and dibenamine)  in about the ratio of 1: 24. In. Text- 
figs.  1 and 2,  50 gg./mh of ovomucoid produced about a 5.5 per cent increase 
in tissue water; 0.5 gg./ml, of 5-hydroxytryptamine combined with 12 ug./mi. 
of histamine produced  a  similar  rise in tissue water.  If both histamine and 
5-hydroxytryptamine were  released  by  50  t~g./ml,  of  ovomucoid,  then  on 
blocking the  5-hydroxytryptamine component one  might expect  a  residual 
edema equM to that produced by 12 #g./ml. of histamine. In the first experi- 
ment, Text-fig.  1, and in two other experiments  not given in detail here,  the 
increase in tissue  water produced by 50 ~g./ml. of ovomucoid in dibeuamine 
treated rats ranged from 1.2  to 2.5  per cent. This closely approximates the 
increase  in tissue  water,  1.8  per  cent, produced by 12 gg./ml, of histamine 
administered alone. 
The Effects of Ovomucoid, 5-Hydroxytryptamine,  and Histamine  on Mast Cells 
and the Effect of Dibenamine and PyriIamine  on Mast Cell Damage.J 
Since the edema produced by 5-hydroxytryptamine, closely resembled  that 
produced by ovomucoid,  it was  desirable  to investigate its effects on mast 
cells. The effects of ovomucoid and histamine on mast ceils were also exam- 
ined. It was of interest to determine whether the inhibition of the ovomucoid 
response by pyrilamine and dibenamine  affected mast cell damage. 
Two doses of each agent were tested: ovomucoid 50 and 1000 gg./ml., histamine S0 and 
1000 gg./ml.,  and 5-hydroxytryptamine  1  and 20 ~tg./ml.  The lower  concentration  was selected 
to produce a 3 to 5 per cent increase in tissue water and the high concentration  to produce 406  5-HYDROXYTRYPTAMIN'E  AND  HISTAMINE  AND  VASCULAR  INJURY 
run'mum edema, or about a 10 per cent increase in tissue water. Saline and each dose of the 
three agents were tested in two untreated rats and in two rats treated with both dibenamine 
and pyrilamlne. Rats were sacrificed  2 hours after challenge and each  full thickness paw skin 
was obtained for histologic section. Since both fore and hind paws were injected, sections of 
four paws injected with each agent were evaluated. The microscopic  evidence of edema and 
the degree of mast cell damage with spill of mast cell granules into surrounding tissue were 
graded separately. The findings for each group of four paws injected with the same substance 
were comparable. 
In untreated rats saline produced a  slight edema and a  few damaged mast 
cells,  presumably due  to  the  trauma  of injection and  removal of the skin. 
Neither  concentration  of  5-hydroxytryptamine  or  of  histamine  produced 
greater mast  cell damage,  than  saline,  though  the  edema  produced  by the 
higher  concentrations  was  severe.  The  lower  dose  of  ovomucoid produced 
minimal  but  distinct mast  cell changes  in  excess of the  controls, while  the 
higher dose produced wide spread mast cell damage. 
In  animals  treated with  dibenamine and  pyrilamine prior  to  injection of 
any of the injurious agents there was  no edema. Following injection of saline 
and  either concentration of 5-hydroxytryptamine or histamine  the observed 
changes were similar to those in untreated rats. Following injection of either 
concentration  of  ovomucoid  there  was  distinct  and  substantial  mast  cell 
damage with spill of granules into the surrounding tissue; in the absence of 
edema  this appeared  even more marked  than in  the untreated rats.  Photo- 
micrographs of some representative sections, shown in Figs.  2  to 5,  demon- 
strate the principal findings. 
The different sites of action of ovomucoid and of histamine or 5-hydroxy- 
tryptamine are clearly shown by the difference in effects on mast cells. Damage 
to mast cells with spill of granules into the surrounding tissue is not second- 
ary to the production of edema.  Furthermore, the inhibition of edema pro- 
duced  by ovomucoid is  not  mediated  through  the  prevention of mast  cell 
damage,  but  rather  through  the  effects of the antagonists  on  "released" 5- 
hydroxytryptamine and histamine. 
The Mechanism of Edema Production by 48[80, Dextran, and Testis Extract.-- 
Under similar conditions the mode of action of 48/80, dextran, and testis 
extract were compared with ovomucoid. The effects of these agents on mast 
cells was determined for two concentrations of each agent. One was the con- 
centration which  produced about a  5  per  cent increase in  tissue  water and 
the  other  was  twenty  times  this  concentration.  It  was  observed that  each 
agent produced mast cell damage with spill of granules into the surrounding 
tissue similar  to  that produced by the  comparable concentration of ovomu- 
cold. 
The effect of dibenamlne and pyrilamine as antagonists for the edema pro- 
duced by these  mast  cell--damaging agents was tested. The concentration of DONALD A.  ROWLEY AND EARL P.  BENDITT  407 
each injurious substance was that which was found to produce about a  5  per 
cent  increase  in  tissue  water.  Dextran  50  #g./ml.,  48/80  5  ~g./ml.,  testis 
extract  150  #g./ml., and ovomucoid 50 #g./ml. were each tested in four con- 
trol  rats  and  in  four  rats  treated  with:  (a)  dibenamine,  (b)  pyrilamine, or 
(c)  dibenamine  and  pyrilamine.  The  edema  and  bluing  were  graded  in  the 
TABLE  I 
The Effect of Dibenamine and Pyrilamine Alone and in Combination on the Gross 
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* Dibenamine 8 mg./kg, and pyrilamine 4 mg./kg. 
:~ The numbers in columns are the recorded responses for individual rats; the italicized 
number is the average response for four rats, to the nearest whole number. 
§ Dibenamine diluting fluid diluted in saline. 
gross.  The  results,  presented  in  Table  I,  show  that  the  drugs  affected sim- 
ilarly the  edema produced  by these four agents.  Dibenamine  alone partially 
inhibited,  pyrilamine alohe had  no  effect, and  the  two  drugs  together  com- 
pletely inhibited  the  edema produced  by each  agent.  Histologic  sections  of 
the  paw  skins  showed  that  the  drugs,  administered  in  combination  did  not 
prevent mast cell damage. The results indicate that the mechanism o1 edema 
production was similar for these four mast cell-damaging agents. 408  5-HYDROXYTRYPTAMINE  AND  HIST~MT~E  AND  VASCULAR  II~URY 
DISCUSSION 
The  experiments described demonstrate  clearly that  several agents  which 
damage  mast  cells  in  the  rat  release  a  substance in  addition  to histamine. 
This  substance  behaves  in  vivo like  5-hydroxytryptamiue.  To  this  we  can 
now add the following ancillary evidence (2): Mast cells prepared from peri- 
toneal  washing  of  rats  contain  a  material  which  is  indistinguishable  from 
5-hydroxytryptamine by its biological  and chemical  properties and  this sub- 
stance  is present  in rat  skin  and  subcutaneous tissues in proportion  to  the 
mast  cell  content of these tissues.  Histamine  is also found in these isolated 
mast cells in the quantity expected from measurements of the volume of mast 
cells and the concentration of mast cells in skin. The ratio of 5-hydroxytrypt- 
amine  to  histamine  ranged  between 1:16  and  1:26  by the  two methods of 
estimation used. The combined evidence makes it very likely that 5-hydroxy- 
tryptamine is the edema-producing agent released by substances which dam- 
age mast cells. 
Tryptamine  also  produces  edema  and  increased  capillary  permeability 
when injected subcutaneously in rats.  On a  weight basis it requires 10 times 
as  much  tryptamine  as  5-hydroxytryptamine  to  cause  equivalent  edema. 
This is'in keeping with the relative reactivity of these two substances in other 
biological  systems  (4),  and  suggests  that  a  5-hydroxytryptamine  receptor 
site is involved (5).  Tyramine in concentrations up to  1000 t~g./ml,  did not 
produce increased  vascular permeability in rats (6). 
Dihenamine  is  best known  for  its  adrenergic  blocking properties  (7);  its 
antagonism  to  5-hydroxytryptamine  has  been  more  recently  described  (5). 
It  seems  unlikely from evidence now available that  inhibition  of edema by 
dihenamine  is  related  to  its  adrenergic  blocking  activity.  We  have  found 
that  neither  adrenalin  nor noradrenalin  in concentration up to  1000 ~g./ml. 
injected subcutaneously produces edema. In the rat  the edema produced by 
egg white is partially inhibited by both adrenalin and noradrenalin  (8).  Con- 
sequenfly, if the adrenergic  blocking effects of dibenamine were involved, one 
might reasonably expect enhancement of edema rather than inhibition. 
Pyrilamine is a highly specific and potent antihistaminic  agent (9) and for 
this reason was selected for our studies. We have found that pyrihenzamine 
does  not  inhibit  the  edema  produced  in  the  rat  by  5-hydroxytryptamine; 
its  antihistaminic  activity in  the  rat  is  similar  to  pyrilamine  but  it  is  less 
potent than pyrilamine on a weight basis. It is of interest that doses of pyrll- 
amine of 2 rag.  or more/kg, regularly potentiate slightly the edema produced 
by  5-hydroxytryptamine  or  the  mast  cell-damaglng  agents.  This  coincides 
with  an  observation  that  pyrilamine  potentiates  the  5-hydroxytryptamine 
induced contraction of the cat's nictitating membrane (10). 
The  doses of dihenamine  and pyrilamine  were higher  than  the minimum 
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agents. If the dose of each drug is decreased to one-half  that used in the pres- 
ent  experiments  there  is  complete  inhibition  of  the  local  edema  produced 
by the subcutaneous injection of ovomucoid or the severe generalized  edema 
produced by the intravenous injection of ovomucoid. 
The  capacity  of  5-hydroxytryptamine  (and  tryptamine)  to  produce  in- 
creased vascular permeability and edema has not been previously described. 
The site and mechanism of this action are not yet evident. It is known that 
5-hydroxytryptamine  is  present  in  the  nervous  system  (11),  that  it  has  a 
competitive action with acetylcholine on the molluscan heart  (12),  and  that 
it  initiates  nerve  reflexes  (13).  These  actions  suggest  that  5-hydroxytrypt- 
amine  may be another  neurohumor.  In  this  regard  it has been reported re- 
cently that  the  edema  produced on  the  palmar  surface of the hind  feet of 
rats by testis extract is inhibited by procaine block or section of the sciatic 
nerve  (14).  However, in our hands,  nerve  section or block does not  inhibit 
the edema produced by 5-hydroxytryptamine or ovomucoid. It is of interest 
that  neither  acetylcholine nor carbamylcholine-chloride in doses up to  1000 
#g./ml.  produce  edema  in  rats'  feet  and  that  atropine  in  full  therapeutic 
doses does not inhibit the edema produced by mast cell--damaging agents (15). 
Erspamer presented evidence for an antidiuretic  action of 5-hydroxytrypt- 
amine in rats  and  suggested that  the site of action was in  the kidney  (16). 
It is significant  that he found the antidiuretic action to be several times more 
effective following  subcutaneous  than  following  intraperitoneal  or  intrave- 
nous  injection.  Computations  from  our  data  suggest  that  there  would be 
sufficient local loss of water in subcutaneous tissue with the doses of 5-hydrox- 
ytryptamine he used to account for the reported reduction in urine  output. 
It has been suggested that  5-hydroxytryptamine liberates histamine  (17). 
Our experiments do not bear this out: There are no apparent mast cell--dam- 
aging  effects with  large doses of 5-hydroxytryptamine;  the edema produced 
by histamine  can be completely inhibited  without  affecting  the  edema pro- 
duced  by 5-hydroxytryptamine.  Furthermore  we  have  not  found  following 
repeated  local  injections  of  5-hydroxytryptamine  the  refractory  state  seen 
following  repeated  injections  of ovomucoid  (1)  or  other  known  "histamine 
releasers" (18). 
The in vivo assay methods used in  these studies have potential  value for 
assessing  the actions of both edema-producing agents  and drug antagonists. 
For  example,  using  this  method  we  have  shown  that  chlorpromazine  and 
phenergan  are  potent  5-hydroxytryptamine  antagonists  as  well  as  antihist- 
aminics  (19). 
The  capacity of 5-hydroxytryptamine  to  produce increased  vascular  per- 
meability upon local injection in certain sites m the rat has been demonstrated. 
It will be remarkable if this action of 5-hydroxytryptamine and its association 
with mast cells is unique to the rat.  The present studies offer no explanation 410  5-HYDROXYTRYPTAMII~E AND HISTAMINE AND VASCULAR INJURY 
of the mechanism of mast  cell damage produced by substances of such widely 
differing  origin  and apparent  composition as ovomucoid, crude testis extract, 
dextran, and 48/80. 
SUM3~A.Ry 
Each  of  the  four  agents,  ovomucoid, dextran,  48/80,  and  testis  extract, 
when injected beneath  the skin of the dorsa of the paws of rats produces a 
local vascular injury characterized by a  protein-rich  edema. Each agent also 
produces damage to mast cells. 
Either  5-hydroxytryptamine  or  histamine  produces  a  response  similar  in 
the gross to that  elicited  by the agents  which damage mast  cells;  however, 
neither  of these two agents produces mast  cell  damage.  On a  weight  basis 
5-hydroxytryptamine  is  a  much  more  potent  edema-producing  agent  than 
histamine. 
The edema-producing action of 5-hydroxytryptamine can be differentiated 
from  the  similar  action of histamine  by the use of specific  antagonists;  di- 
benamine  is  a  5-hydroxytryptamine  antagonist  and  pyrilamine  a  histamine 
antagonist. 
The  edema  produced  by the  mast  cell-damaging  agents  is  partially  in- 
hibited by dibenamine but is not diminished by pyrilamine.  It is completely 
inhibited by treatment of rats with both drugs. 
The drugs which inhibit  edema do not prevent mast cell damage by ovo- 
mucoid, dextran, 48/80, or testis extract. 
The  observations  are  consistent  with  the  hypothesis  that  agents  which 
damage  mast  cells,  "release"  both 5-hydroxytryptamine and histamine  and 
that in the rat the edema associated with mast cell damage is mediated largely 
by 5-hydroxytryptamine. 
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EXPLANATION OF PLATES 
PLATE  18 
FIG. 1. Gross edema and bluing 2 hours after subcutaneous injection of ovomucoid, 
histamine, 5-hydroxytryptamine, and saline respectively into the paws of two normal 
rats. Each rat was injected intravenously with 2 rag. of Evans blue just prior to local 
injections. 
FIG. 2. Section of rat paw skin stained with toluidine blue for demonstrating mast 
cells. Paw skin of a normal rat injected subcutaneously with 5-hydroxytryptamine 20 
~g./ml. It shows severe edema. X  103. THE  JOURNAL OF EXPERIMENTAL  MEDICINE VOL. 103  PLATE  18 
(Rowley and Benditt: 5-hydroxytryptarnine and histamine and vascular injury) PLATE 19 
FIO.  3. Sections  of  rat  paw  skin  stained  with  toluidine  blue  for  demonstrating 
mast cells.  Same  as  Fig.  2.  Shows  edema and intact  or only slightly  damaged  mast 
cells.  ×  360. 
FIG. 4. Paw skin of a rat treated with dibenamine and pyrilamine and injected sub- 
cutaneously with ovomucoid 1000/zg./ml.  ×  96. 
FIo. 5. Same as Fig. 4. Shows no edema and  marked  widespread  disruption of mast 
cells.  X  360. TIlE JOURNAL OF EXPERIMENTAL  MEDICIN'E VOL. 103  PLATE  19 
(Rowley and Benditt: 5-hydroxytryptamine and histamine and vascular injury) 